| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
153,205 |
133,793 |
$16.61M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
116,174 |
42,583 |
$10.29M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
66,274 |
57,635 |
$10.02M |
| J1745 |
Injection, infliximab, excludes biosimilar, 10 mg |
6,141 |
3,203 |
$7.85M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
46,799 |
42,536 |
$7.02M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
41,951 |
38,768 |
$6.14M |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
57,297 |
51,118 |
$5.62M |
| J2350 |
Injection, ocrelizumab, 1 mg |
135 |
107 |
$3.62M |
| J1459 |
Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg |
2,582 |
684 |
$3.47M |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
4,520 |
3,254 |
$3.42M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
9,508 |
7,115 |
$3.27M |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
21,422 |
19,265 |
$3.11M |
| 59025 |
Fetal non-stress test |
15,370 |
10,655 |
$3.01M |
| G0378 |
Hospital observation service, per hour |
36,378 |
13,709 |
$2.89M |
| J0741 |
Injection, cabotegravir and rilpivirine, 2mg/3mg |
457 |
370 |
$2.56M |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
12,827 |
9,278 |
$2.45M |
| J3380 |
Injection, vedolizumab, intravenous, 1 mg |
447 |
350 |
$2.41M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
8,593 |
7,239 |
$2.31M |
| 70450 |
Computed tomography, head or brain; without contrast material |
7,120 |
5,840 |
$2.06M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
14,820 |
13,863 |
$2.01M |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
2,197 |
1,650 |
$1.81M |
| J0178 |
Injection, aflibercept, 1 mg |
1,602 |
1,190 |
$1.77M |
| 81513 |
|
10,548 |
9,103 |
$1.70M |
| 96415 |
|
4,478 |
3,609 |
$1.66M |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
14,230 |
2,072 |
$1.65M |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
2,079 |
1,987 |
$1.62M |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
4,806 |
2,855 |
$1.59M |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
8,635 |
7,565 |
$1.55M |
| 67028 |
Intravitreal injection of a pharmacologic agent |
7,796 |
6,899 |
$1.53M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
14,392 |
12,729 |
$1.48M |
| J2357 |
Injection, omalizumab, 5 mg |
1,186 |
436 |
$1.45M |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
9,071 |
8,626 |
$1.42M |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
2,666 |
2,244 |
$1.33M |
| 80051 |
|
121,315 |
93,930 |
$1.20M |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
4,029 |
3,306 |
$1.17M |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
3,896 |
3,501 |
$1.14M |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
8,301 |
7,735 |
$1.04M |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
13,246 |
12,072 |
$1.04M |
| 95886 |
|
3,691 |
3,459 |
$1.04M |
| 92134 |
|
20,088 |
18,428 |
$1.03M |
| 64615 |
|
3,266 |
2,887 |
$1.01M |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
1,829 |
1,524 |
$970K |
| 80053 |
Comprehensive metabolic panel |
46,934 |
40,425 |
$962K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
8,283 |
6,986 |
$887K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
1,343 |
1,086 |
$842K |
| Q5104 |
Injection, infliximab-abda, biosimilar, (renflexis), 10 mg |
735 |
298 |
$837K |
| 93798 |
|
12,475 |
2,282 |
$705K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
5,934 |
3,295 |
$698K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
2,628 |
2,273 |
$688K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
33,206 |
28,214 |
$671K |
| 97542 |
|
16,696 |
13,900 |
$664K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
3,069 |
2,745 |
$663K |
| 62323 |
|
1,258 |
1,121 |
$644K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
166,938 |
141,157 |
$634K |
| 84443 |
Thyroid stimulating hormone (TSH) |
32,462 |
29,100 |
$630K |
| 73030 |
|
9,633 |
8,598 |
$626K |
| 82565 |
|
131,434 |
102,041 |
$623K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
25,958 |
18,525 |
$616K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
5,456 |
4,891 |
$611K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
2,255 |
2,053 |
$609K |
| 90651 |
|
1,928 |
1,539 |
$595K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
17,167 |
7,353 |
$591K |
| H0015 |
Alcohol and/or drug services; intensive outpatient (treatment program that operates at least 3 hours/day and at least 3 days/week and is based on an individualized treatment plan), including assessment, counseling; crisis intervention, and activity therapies or education |
4,883 |
850 |
$590K |
| 73564 |
|
7,092 |
6,579 |
$590K |
| 93458 |
|
515 |
406 |
$583K |
| 71046 |
Radiologic examination, chest; 2 views |
24,647 |
21,947 |
$561K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
33,198 |
28,210 |
$554K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
14,847 |
8,214 |
$549K |
| 19318 |
|
102 |
82 |
$529K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
2,064 |
1,895 |
$520K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
21,964 |
9,467 |
$500K |
| 92250 |
|
7,367 |
7,089 |
$500K |
| 73630 |
|
8,246 |
7,450 |
$495K |
| 95885 |
|
1,614 |
1,515 |
$494K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,652 |
1,425 |
$488K |
| 73502 |
|
7,503 |
6,785 |
$486K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
34,741 |
31,592 |
$484K |
| 80076 |
|
42,787 |
36,184 |
$481K |
| 43235 |
|
1,001 |
828 |
$479K |
| 80061 |
Lipid panel |
29,533 |
27,025 |
$475K |
| 49083 |
|
1,099 |
540 |
$472K |
| 95811 |
|
582 |
527 |
$472K |
| 87481 |
|
22,138 |
9,802 |
$471K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
38,622 |
32,063 |
$463K |
| 86850 |
|
18,187 |
15,564 |
$455K |
| Q5103 |
Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg |
994 |
439 |
$452K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
2,740 |
1,890 |
$444K |
| J0485 |
Injection, belatacept, 1 mg |
1,058 |
423 |
$442K |
| J9312 |
Injection, rituximab, 10 mg |
97 |
69 |
$441K |
| J7307 |
Etonogestrel (contraceptive) implant system, including implant and supplies |
379 |
288 |
$439K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
20,477 |
18,683 |
$439K |
| J3032 |
Injection, eptinezumab-jjmr, 1 mg |
161 |
144 |
$433K |
| 74183 |
|
1,604 |
1,440 |
$433K |
| 99215 |
Prolong outpt/office vis |
3,974 |
3,299 |
$424K |
| 90870 |
|
1,271 |
451 |
$421K |
| 97162 |
|
8,396 |
7,380 |
$419K |
| 70496 |
|
1,410 |
1,196 |
$417K |
| J1439 |
Injection, ferric carboxymaltose, 1 mg |
523 |
287 |
$415K |
| 64415 |
|
1,208 |
902 |
$409K |
| 97161 |
|
7,319 |
6,554 |
$396K |
| 70491 |
|
1,311 |
1,131 |
$388K |
| 92083 |
|
4,941 |
4,686 |
$383K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
1,988 |
1,797 |
$381K |
| 97113 |
|
3,962 |
1,523 |
$368K |
| H0012 |
Alcohol and/or drug services; sub-acute detoxification (residential addiction program outpatient) |
1,158 |
327 |
$365K |
| 36415 |
Collection of venous blood by venipuncture |
177,317 |
151,571 |
$359K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,390 |
2,979 |
$353K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
2,976 |
2,732 |
$335K |
| 73221 |
|
1,225 |
1,126 |
$325K |
| J3490 |
Unclassified drugs |
23,080 |
13,916 |
$318K |
| 71250 |
|
2,563 |
2,341 |
$317K |
| 73610 |
|
5,286 |
4,722 |
$317K |
| 86780 |
|
20,961 |
18,018 |
$314K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
1,636 |
1,462 |
$312K |
| 84520 |
|
125,308 |
97,503 |
$311K |
| 64493 |
|
446 |
386 |
$309K |
| 94375 |
|
2,829 |
2,590 |
$305K |
| 85027 |
|
49,530 |
35,646 |
$304K |
| 81220 |
CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants |
1,093 |
931 |
$298K |
| 72197 |
|
921 |
837 |
$297K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
682 |
587 |
$295K |
| 72141 |
|
1,421 |
1,257 |
$290K |
| 27130 |
|
66 |
50 |
$290K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
1,904 |
1,793 |
$284K |
| 86803 |
|
16,487 |
14,506 |
$267K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
21,573 |
18,954 |
$263K |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
2,924 |
2,668 |
$259K |
| 86900 |
|
19,161 |
15,767 |
$259K |
| 82728 |
|
15,190 |
13,703 |
$258K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
13,287 |
11,492 |
$252K |
| 84439 |
|
10,825 |
9,555 |
$240K |
| 90837 |
Psychotherapy, 53 minutes with patient |
2,098 |
1,448 |
$237K |
| 66982 |
|
323 |
253 |
$235K |
| 97016 |
|
5,255 |
1,811 |
$228K |
| 92133 |
|
5,258 |
4,992 |
$227K |
| 97535 |
Self-care/home management training, each 15 minutes |
6,641 |
4,247 |
$224K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
3,572 |
2,379 |
$217K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
1,252 |
946 |
$214K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
284 |
259 |
$210K |
| 76770 |
|
1,249 |
1,130 |
$210K |
| 82607 |
|
10,547 |
9,593 |
$206K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
21,991 |
17,333 |
$206K |
| C9257 |
Injection, bevacizumab, 0.25 mg |
3,764 |
2,687 |
$202K |
| 94726 |
|
3,269 |
3,031 |
$200K |
| 87088 |
|
19,104 |
16,316 |
$198K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
308 |
239 |
$198K |
| 93308 |
|
711 |
599 |
$190K |
| 94618 |
|
1,920 |
1,776 |
$190K |
| 97163 |
|
3,850 |
3,625 |
$189K |
| J0897 |
Injection, denosumab, 1 mg |
285 |
259 |
$187K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
8,293 |
6,986 |
$184K |
| 85610 |
|
40,919 |
31,327 |
$183K |
| 29848 |
|
115 |
73 |
$178K |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
706 |
536 |
$177K |
| 64721 |
|
243 |
190 |
$175K |
| 72110 |
|
4,432 |
4,158 |
$174K |
| 97165 |
|
2,354 |
1,977 |
$174K |
| 87340 |
|
13,409 |
11,794 |
$171K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
10,129 |
7,296 |
$169K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
2,958 |
2,703 |
$164K |
| G0121 |
Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk |
247 |
192 |
$163K |
| 76536 |
|
1,271 |
1,161 |
$163K |
| 88341 |
|
3,840 |
795 |
$161K |
| 83735 |
|
67,520 |
48,116 |
$159K |
| 72158 |
|
898 |
789 |
$158K |
| 86140 |
|
15,057 |
12,982 |
$157K |
| 36430 |
|
950 |
698 |
$157K |
| 82947 |
|
96,058 |
72,291 |
$156K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
35,978 |
30,124 |
$155K |
| 94729 |
|
3,048 |
2,826 |
$153K |
| 87505 |
|
1,352 |
955 |
$153K |
| G0260 |
Injection procedure for sacroiliac joint; provision of anesthetic, steroid and/or other therapeutic agent, with or without arthrography |
482 |
418 |
$152K |
| 97116 |
|
5,466 |
2,460 |
$152K |
| 76820 |
|
2,231 |
1,285 |
$150K |
| 94010 |
|
1,756 |
1,600 |
$149K |
| 93296 |
|
6,042 |
5,800 |
$145K |
| 64450 |
|
1,035 |
731 |
$145K |
| 74174 |
|
1,681 |
1,428 |
$143K |
| 77073 |
|
1,748 |
1,685 |
$142K |
| 86706 |
|
8,557 |
7,540 |
$141K |
| 78264 |
|
486 |
432 |
$141K |
| 75561 |
|
457 |
421 |
$139K |
| 84466 |
|
14,568 |
13,169 |
$138K |
| J2323 |
Injection, natalizumab, 1 mg |
19 |
12 |
$138K |
| 86704 |
|
7,818 |
6,656 |
$137K |
| 70543 |
|
391 |
356 |
$136K |
| 88185 |
|
4,342 |
585 |
$135K |
| 97166 |
|
2,619 |
2,209 |
$134K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
1,127 |
907 |
$132K |
| 86480 |
|
4,236 |
3,695 |
$132K |
| G0476 |
Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test |
4,755 |
4,246 |
$131K |
| 27447 |
|
34 |
27 |
$131K |
| 74178 |
|
468 |
425 |
$130K |
| 81001 |
|
47,897 |
41,354 |
$129K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
9,411 |
8,389 |
$127K |
| 83540 |
|
14,144 |
12,724 |
$127K |
| 87640 |
|
3,673 |
3,392 |
$126K |
| 86832 |
|
4,406 |
3,773 |
$125K |
| 72156 |
|
828 |
743 |
$124K |
| 73562 |
|
3,905 |
3,396 |
$124K |
| 10060 |
|
662 |
554 |
$124K |
| P9047 |
Infusion, albumin (human), 25%, 50 ml |
485 |
232 |
$123K |
| 70487 |
|
396 |
328 |
$123K |
| 73700 |
|
723 |
625 |
$123K |
| 83970 |
|
6,757 |
5,902 |
$122K |
| 75574 |
|
402 |
347 |
$122K |
| 84484 |
|
38,809 |
25,896 |
$121K |
| 72084 |
|
2,255 |
2,165 |
$118K |
| J7297 |
Levonorgestrel-releasing intrauterine contraceptive system (liletta), 52 mg |
301 |
235 |
$117K |
| 76830 |
Ultrasound, transvaginal |
2,962 |
2,658 |
$117K |
| 72050 |
|
1,971 |
1,810 |
$116K |
| 93017 |
|
1,467 |
1,256 |
$116K |
| 93971 |
|
1,367 |
1,168 |
$116K |
| 87522 |
Neg quan hep c or qual rna |
3,377 |
2,902 |
$115K |
| 86901 |
|
19,155 |
15,762 |
$115K |
| J1750 |
Injection, iron dextran, 50 mg |
991 |
397 |
$114K |
| 93321 |
|
494 |
448 |
$114K |
| 82570 |
|
14,931 |
11,995 |
$111K |
| 90791 |
Psychiatric diagnostic evaluation |
460 |
363 |
$111K |
| 93970 |
|
730 |
631 |
$111K |
| 97035 |
|
1,538 |
628 |
$109K |
| 87902 |
|
581 |
500 |
$108K |
| 86038 |
|
4,616 |
3,582 |
$108K |
| 90834 |
Psychotherapy, 45 minutes with patient |
1,036 |
803 |
$108K |
| 76981 |
|
748 |
702 |
$107K |
| 71271 |
|
519 |
481 |
$106K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
15,648 |
11,751 |
$105K |
| 88307 |
|
1,197 |
810 |
$103K |
| 70486 |
|
1,322 |
1,153 |
$103K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,025 |
942 |
$101K |
| 73130 |
|
2,984 |
2,545 |
$101K |
| 87536 |
|
2,499 |
2,186 |
$100K |
| 86235 |
|
7,372 |
1,050 |
$98K |
| 71045 |
Radiologic examination, chest; single view |
13,825 |
11,301 |
$97K |
| 76801 |
|
2,067 |
1,773 |
$97K |
| 64405 |
|
287 |
258 |
$97K |
| 93451 |
|
74 |
62 |
$97K |
| C8929 |
Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography |
434 |
362 |
$95K |
| 94660 |
|
977 |
471 |
$95K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
842 |
693 |
$94K |
| 87077 |
|
11,360 |
5,725 |
$91K |
| 36224 |
|
51 |
37 |
$91K |
| 80197 |
|
6,035 |
3,343 |
$87K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
2,776 |
2,353 |
$87K |
| 76882 |
|
755 |
654 |
$87K |
| 31624 |
|
162 |
128 |
$87K |
| 16020 |
|
2,000 |
1,354 |
$86K |
| 86360 |
|
1,645 |
1,447 |
$84K |
| 82784 |
|
9,374 |
3,739 |
$84K |
| 77080 |
|
1,138 |
1,063 |
$83K |
| 73120 |
|
1,043 |
939 |
$83K |
| 72082 |
|
1,830 |
1,725 |
$82K |
| 97167 |
|
2,089 |
1,958 |
$82K |
| 52356 |
|
50 |
38 |
$82K |
| 90832 |
Psychotherapy, 30 minutes with patient |
1,027 |
777 |
$81K |
| H0005 |
Alcohol and/or drug services; group counseling by a clinician |
1,157 |
512 |
$80K |
| 94060 |
|
631 |
585 |
$80K |
| 93975 |
|
530 |
478 |
$79K |
| 73110 |
|
1,824 |
1,548 |
$79K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
8,605 |
7,554 |
$79K |
| 87641 |
|
3,733 |
3,448 |
$78K |
| 20610 |
|
387 |
326 |
$77K |
| 20680 |
|
90 |
65 |
$76K |
| 70498 |
|
1,465 |
1,233 |
$76K |
| 72100 |
|
2,023 |
1,797 |
$75K |
| 91200 |
|
603 |
561 |
$74K |
| 43264 |
|
93 |
68 |
$73K |
| 43237 |
|
191 |
153 |
$73K |
| J0491 |
Injection, anifrolumab-fnia, 1 mg |
18 |
13 |
$71K |
| 29881 |
|
104 |
81 |
$70K |
| 86003 |
|
7,188 |
531 |
$70K |
| 87150 |
|
2,663 |
2,367 |
$70K |
| 82105 |
|
4,250 |
3,926 |
$69K |
| 73200 |
|
454 |
394 |
$69K |
| 87517 |
|
1,625 |
1,481 |
$69K |
| 74018 |
|
1,947 |
1,573 |
$68K |
| 85652 |
|
13,637 |
11,914 |
$67K |
| 86833 |
|
4,410 |
3,771 |
$66K |
| 20553 |
|
378 |
315 |
$66K |
| 73560 |
|
1,127 |
988 |
$65K |
| 86160 |
|
5,433 |
2,534 |
$65K |
| 82248 |
|
17,117 |
13,290 |
$65K |
| 81370 |
|
475 |
394 |
$65K |
| 95715 |
|
110 |
44 |
$65K |
| 99201 |
|
652 |
638 |
$64K |
| 84153 |
|
3,490 |
3,173 |
$63K |
| Q0222 |
Injection, bebtelovimab, 175 mg |
68 |
66 |
$63K |
| 88184 |
|
696 |
595 |
$63K |
| 86364 |
|
4,471 |
2,163 |
$62K |
| 92025 |
|
735 |
684 |
$62K |
| 72146 |
|
542 |
488 |
$61K |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
179 |
119 |
$61K |
| 83880 |
|
11,367 |
9,080 |
$60K |
| 80069 |
|
2,836 |
1,881 |
$60K |
| 72157 |
|
610 |
531 |
$59K |
| 84100 |
|
37,467 |
28,289 |
$58K |
| 95909 |
|
407 |
374 |
$58K |
| 64483 |
|
91 |
80 |
$58K |
| 81329 |
|
948 |
801 |
$57K |
| 73590 |
|
1,629 |
1,409 |
$57K |
| 74220 |
|
784 |
696 |
$56K |
| 84702 |
|
6,092 |
4,532 |
$56K |
| 85730 |
|
19,073 |
13,928 |
$56K |
| 93350 |
|
530 |
446 |
$55K |
| 93976 |
|
225 |
179 |
$54K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
5,273 |
4,237 |
$54K |
| 93325 |
|
593 |
519 |
$54K |
| 12001 |
|
304 |
249 |
$53K |
| 86762 |
|
3,929 |
3,540 |
$53K |
| 87497 |
|
1,762 |
1,152 |
$53K |
| 72131 |
|
1,834 |
1,563 |
$52K |
| 92136 |
|
1,247 |
1,153 |
$52K |
| 93299 |
|
2,068 |
1,994 |
$51K |
| 76813 |
|
388 |
354 |
$51K |
| 82043 |
|
6,378 |
5,858 |
$50K |
| 84403 |
|
2,359 |
2,136 |
$50K |
| 73503 |
|
596 |
554 |
$49K |
| 81222 |
|
557 |
494 |
$48K |
| 64635 |
|
74 |
59 |
$46K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
3,160 |
2,891 |
$46K |
| 72070 |
|
1,076 |
952 |
$45K |
| 82310 |
|
8,697 |
7,735 |
$45K |
| 83520 |
|
2,837 |
1,461 |
$45K |
| 95910 |
|
495 |
460 |
$44K |
| 82670 |
|
1,433 |
1,310 |
$44K |
| 92020 |
|
745 |
701 |
$44K |
| 76512 |
|
591 |
513 |
$44K |
| 73080 |
|
1,136 |
998 |
$43K |
| 95912 |
|
391 |
363 |
$42K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
487 |
368 |
$42K |
| 58300 |
|
337 |
269 |
$41K |
| 43244 |
|
77 |
55 |
$41K |
| 86923 |
|
1,866 |
713 |
$41K |
| 64494 |
|
416 |
329 |
$41K |
| 82040 |
|
4,249 |
3,773 |
$41K |
| G0239 |
Therapeutic procedures to improve respiratory function or increase strength or endurance of respiratory muscles, two or more individuals (includes monitoring) |
1,257 |
215 |
$40K |
| 92235 |
|
351 |
325 |
$39K |
| 62328 |
|
75 |
63 |
$39K |
| 84460 |
|
7,142 |
5,530 |
$38K |
| 86708 |
|
2,412 |
2,155 |
$38K |
| 86787 |
|
3,689 |
3,152 |
$38K |
| 81373 |
|
264 |
239 |
$38K |
| 84703 |
|
29,311 |
25,273 |
$37K |
| 72040 |
|
935 |
829 |
$37K |
| 84450 |
|
6,800 |
5,196 |
$37K |
| 82247 |
|
3,780 |
2,580 |
$36K |
| 00104 |
|
1,433 |
481 |
$36K |
| 96367 |
|
1,069 |
795 |
$36K |
| 83013 |
|
637 |
593 |
$36K |
| 93922 |
|
563 |
503 |
$36K |
| 73552 |
|
1,034 |
894 |
$36K |
| H2036 |
Alcohol and/or other drug treatment program, per diem |
445 |
41 |
$36K |
| 87081 |
|
3,006 |
2,633 |
$35K |
| 97597 |
|
359 |
293 |
$35K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
8,425 |
7,322 |
$34K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
171 |
169 |
$34K |
| 62321 |
|
62 |
58 |
$34K |
| 83516 |
|
2,067 |
835 |
$34K |
| 82746 |
|
5,134 |
4,617 |
$33K |
| 43249 |
|
100 |
81 |
$32K |
| 95913 |
|
350 |
318 |
$32K |
| 90715 |
|
1,582 |
1,226 |
$32K |
| 82977 |
|
4,656 |
3,285 |
$32K |
| 86376 |
|
1,537 |
1,386 |
$31K |
| 86431 |
|
1,916 |
1,712 |
$31K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
1,479 |
821 |
$30K |
| 97602 |
|
174 |
129 |
$29K |
| 87493 |
|
916 |
789 |
$29K |
| 87070 |
|
3,874 |
2,946 |
$29K |
| 87510 |
|
4,784 |
4,184 |
$29K |
| 97750 |
|
531 |
393 |
$29K |
| 82550 |
|
3,831 |
2,885 |
$29K |
| 72052 |
|
741 |
689 |
$29K |
| 64447 |
|
210 |
158 |
$29K |
| 36589 |
|
76 |
66 |
$28K |
| 86147 |
|
1,209 |
538 |
$28K |
| 66821 |
|
119 |
90 |
$27K |
| 86334 |
|
1,563 |
1,409 |
$27K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
22,844 |
9,938 |
$27K |
| 83721 |
|
2,778 |
2,551 |
$27K |
| 84075 |
|
5,604 |
4,211 |
$27K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
21,035 |
16,876 |
$27K |
| 73140 |
|
434 |
381 |
$27K |
| 01916 |
|
130 |
90 |
$27K |
| 84156 |
|
7,414 |
6,214 |
$27K |
| G2066 |
Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results |
1,841 |
1,754 |
$26K |
| 83001 |
|
1,289 |
1,173 |
$26K |
| 87529 |
|
1,353 |
604 |
$25K |
| 87186 |
|
4,265 |
3,065 |
$25K |
| 84146 |
|
1,327 |
1,194 |
$25K |
| 84270 |
|
1,254 |
1,147 |
$25K |
| 86200 |
|
1,394 |
1,242 |
$25K |
| 86225 |
|
1,929 |
1,670 |
$24K |
| 72128 |
|
1,493 |
1,255 |
$23K |
| 83690 |
|
24,593 |
20,838 |
$23K |
| 84550 |
|
5,179 |
4,303 |
$23K |
| 82103 |
|
1,390 |
823 |
$23K |
| 82533 |
|
994 |
702 |
$23K |
| 90714 |
|
1,168 |
917 |
$23K |
| 84481 |
|
1,691 |
1,533 |
$23K |
| 93320 |
|
186 |
153 |
$23K |
| 70480 |
|
119 |
110 |
$22K |
| 87660 |
|
4,929 |
4,314 |
$22K |
| 87799 |
|
1,825 |
1,402 |
$21K |
| 90686 |
|
985 |
861 |
$21K |
| 97150 |
Therapeutic procedure(s), group (2 or more individuals) |
1,038 |
630 |
$21K |
| 86870 |
|
666 |
511 |
$21K |
| M0247 |
Intravenous infusion, sotrovimab, includes infusion and post administration monitoring |
87 |
83 |
$21K |
| 86015 |
|
1,211 |
683 |
$20K |
| 84480 |
|
1,491 |
1,329 |
$20K |
| 82077 |
|
4,682 |
3,746 |
$20K |
| 80143 |
|
1,633 |
1,358 |
$19K |
| 71100 |
|
617 |
560 |
$19K |
| 83605 |
|
9,092 |
5,492 |
$18K |
| 83021 |
|
1,172 |
1,030 |
$18K |
| 85007 |
|
4,151 |
2,803 |
$18K |
| 86341 |
|
1,104 |
367 |
$18K |
| 80377 |
|
1,086 |
828 |
$18K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
334 |
197 |
$17K |
| 97760 |
|
278 |
223 |
$17K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
14,697 |
7,366 |
$17K |
| 86592 |
|
1,611 |
1,371 |
$17K |
| 73060 |
|
646 |
520 |
$17K |
| 83993 |
|
832 |
745 |
$17K |
| 87480 |
|
4,872 |
4,247 |
$17K |
| 95816 |
|
92 |
84 |
$17K |
| 90935 |
Hemodialysis procedure with single evaluation by a physician |
56 |
27 |
$17K |
| 80320 |
|
685 |
285 |
$16K |
| 57452 |
|
59 |
55 |
$16K |
| 95911 |
|
206 |
190 |
$16K |
| 72114 |
|
900 |
857 |
$16K |
| 78306 |
|
81 |
80 |
$16K |
| J7999 |
Compounded drug, not otherwise classified |
3,517 |
2,665 |
$15K |
| 82803 |
|
5,939 |
3,905 |
$15K |
| 82785 |
|
569 |
504 |
$15K |
| 74022 |
|
272 |
239 |
$15K |
| 76870 |
|
551 |
475 |
$15K |
| 83876 |
|
719 |
634 |
$15K |
| 83655 |
|
630 |
577 |
$15K |
| 75635 |
|
61 |
54 |
$14K |
| 80329 |
|
603 |
493 |
$14K |
| 72202 |
|
329 |
304 |
$14K |
| 70544 |
|
79 |
68 |
$14K |
| 82088 |
|
448 |
361 |
$14K |
| 86381 |
|
870 |
772 |
$14K |
| 85018 |
|
6,435 |
4,229 |
$14K |
| 82627 |
|
532 |
475 |
$14K |
| 81025 |
|
5,898 |
5,053 |
$14K |
| 72190 |
|
219 |
181 |
$14K |
| 82951 |
|
525 |
483 |
$14K |
| 87040 |
|
5,726 |
2,376 |
$14K |
| 82525 |
|
796 |
703 |
$14K |
| 92523 |
|
321 |
274 |
$13K |
| 94625 |
|
451 |
67 |
$13K |
| 84630 |
|
1,184 |
1,057 |
$13K |
| 84165 |
|
1,798 |
1,600 |
$13K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
16,617 |
12,271 |
$13K |
| 87205 |
|
3,451 |
2,587 |
$13K |
| C1776 |
Joint device (implantable) |
662 |
522 |
$13K |
| 73522 |
|
382 |
362 |
$13K |
| 84425 |
|
1,833 |
1,704 |
$13K |
| 85014 |
|
2,935 |
2,016 |
$13K |
| 84590 |
|
1,875 |
1,759 |
$13K |
| 12002 |
|
71 |
66 |
$13K |
| 80074 |
|
1,115 |
909 |
$13K |
| 83921 |
|
1,472 |
1,326 |
$12K |
| 82465 |
|
1,277 |
1,076 |
$12K |
| 73090 |
|
653 |
556 |
$12K |
| 73720 |
|
51 |
49 |
$12K |
| 86644 |
|
1,056 |
854 |
$12K |
| 97012 |
|
280 |
122 |
$12K |
| 83883 |
|
314 |
283 |
$12K |
| 88112 |
|
475 |
383 |
$12K |
| 84207 |
|
880 |
789 |
$12K |
| 96376 |
|
4,506 |
2,867 |
$12K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
2,123 |
1,812 |
$11K |
| 88360 |
|
212 |
118 |
$11K |
| 74160 |
|
62 |
46 |
$11K |
| 30140 |
|
46 |
28 |
$11K |
| 82330 |
|
2,232 |
1,650 |
$11K |
| 86696 |
|
1,782 |
995 |
$11K |
| 86665 |
|
1,267 |
856 |
$11K |
| 83615 |
|
3,026 |
1,989 |
$11K |
| 86593 |
|
862 |
727 |
$11K |
| 93298 |
|
525 |
519 |
$11K |
| 86695 |
|
1,762 |
982 |
$11K |
| 11982 |
|
45 |
38 |
$11K |
| 74230 |
|
91 |
83 |
$11K |
| 83002 |
|
614 |
564 |
$11K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
10,016 |
3,823 |
$10K |
| 87015 |
|
1,940 |
1,267 |
$10K |
| 00731 |
|
3,779 |
3,157 |
$10K |
| 83519 |
|
968 |
422 |
$10K |
| 95700 |
|
89 |
81 |
$10K |
| 29581 |
|
62 |
27 |
$10K |
| 86036 |
|
832 |
732 |
$10K |
| 36600 |
|
513 |
470 |
$10K |
| 86146 |
|
1,020 |
351 |
$10K |
| 82390 |
|
799 |
723 |
$10K |
| 72170 |
|
1,108 |
941 |
$10K |
| 83521 |
|
1,399 |
641 |
$10K |
| 84244 |
|
413 |
369 |
$9K |
| 86255 |
|
1,209 |
105 |
$9K |
| 67228 |
|
41 |
38 |
$9K |
| 84134 |
|
1,033 |
856 |
$9K |
| 73000 |
|
178 |
156 |
$9K |
| 85049 |
|
2,533 |
1,795 |
$9K |
| 72200 |
|
187 |
157 |
$9K |
| 86707 |
|
406 |
352 |
$9K |
| 87154 |
|
107 |
84 |
$9K |
| 84681 |
|
776 |
663 |
$9K |
| 86880 |
|
674 |
481 |
$9K |
| 80323 |
|
301 |
293 |
$9K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
135 |
135 |
$8K |
| 51798 |
|
713 |
566 |
$8K |
| 92285 |
|
193 |
172 |
$8K |
| J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) |
122 |
74 |
$8K |
| 81379 |
|
64 |
57 |
$8K |
| 82164 |
|
503 |
434 |
$8K |
| 88142 |
|
528 |
512 |
$8K |
| 93303 |
Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study |
27 |
25 |
$8K |
| 83525 |
|
394 |
308 |
$8K |
| 92611 |
|
85 |
75 |
$7K |
| 86800 |
|
374 |
342 |
$7K |
| 82952 |
|
469 |
437 |
$7K |
| 80164 |
|
599 |
506 |
$7K |
| 86705 |
|
364 |
332 |
$7K |
| 58301 |
|
62 |
55 |
$7K |
| 81003 |
|
7,041 |
6,419 |
$7K |
| 85379 |
|
2,763 |
2,322 |
$7K |
| 84144 |
|
215 |
174 |
$7K |
| 82140 |
|
1,037 |
820 |
$7K |
| 86709 |
|
738 |
607 |
$7K |
| 62370 |
|
129 |
112 |
$6K |
| 84132 |
|
3,199 |
2,339 |
$6K |
| 86920 |
|
418 |
102 |
$6K |
| 82104 |
|
641 |
581 |
$6K |
| 86765 |
|
491 |
428 |
$6K |
| 83010 |
|
637 |
558 |
$6K |
| 73020 |
|
83 |
76 |
$6K |
| 96368 |
|
319 |
253 |
$6K |
| 94799 |
|
131 |
128 |
$6K |
| G0297 |
Low dose ct scan (ldct) for lung cancer screening |
43 |
41 |
$6K |
| 75565 |
|
549 |
506 |
$6K |
| 84182 |
|
358 |
95 |
$6K |
| J1756 |
Injection, iron sucrose, 1 mg |
80 |
29 |
$6K |
| 73718 |
|
31 |
27 |
$6K |
| 76514 |
|
562 |
520 |
$6K |
| 29916 |
|
13 |
13 |
$6K |
| 82150 |
|
1,010 |
713 |
$6K |
| 88342 |
|
2,391 |
1,660 |
$6K |
| 80178 |
|
383 |
321 |
$6K |
| 82172 |
|
362 |
323 |
$6K |
| 87350 |
|
333 |
290 |
$5K |
| 92225 |
|
262 |
148 |
$5K |
| 93880 |
|
89 |
84 |
$5K |
| 12011 |
|
31 |
30 |
$5K |
| 85045 |
|
1,828 |
1,215 |
$5K |
| 86037 |
|
351 |
291 |
$5K |
| 81050 |
|
614 |
560 |
$5K |
| 82950 |
|
896 |
849 |
$5K |
| 73702 |
|
15 |
13 |
$5K |
| 86301 |
|
325 |
293 |
$5K |
| 88173 |
|
965 |
434 |
$5K |
| 73723 |
|
12 |
12 |
$5K |
| 87449 |
|
1,230 |
586 |
$5K |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
3,424 |
2,205 |
$5K |
| 86735 |
|
219 |
207 |
$5K |
| 86231 |
|
271 |
178 |
$5K |
| G0008 |
Administration of influenza virus vaccine |
1,252 |
1,091 |
$5K |
| 64445 |
|
23 |
15 |
$5K |
| 84446 |
|
527 |
474 |
$4K |
| G0257 |
Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility |
409 |
170 |
$4K |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
1,103 |
508 |
$4K |
| 86258 |
|
374 |
175 |
$4K |
| 74181 |
|
17 |
12 |
$4K |
| 11981 |
|
21 |
13 |
$4K |
| 29823 |
|
63 |
36 |
$4K |
| 95908 |
|
208 |
204 |
$4K |
| 82436 |
|
823 |
610 |
$4K |
| 83498 |
|
241 |
207 |
$4K |
| 74019 |
|
200 |
169 |
$4K |
| 86304 |
|
239 |
198 |
$4K |
| 72193 |
|
13 |
12 |
$4K |
| 89051 |
|
852 |
712 |
$4K |
| 84300 |
|
1,122 |
853 |
$4K |
| 87206 |
|
1,296 |
834 |
$4K |
| 76937 |
|
401 |
314 |
$4K |
| J1611 |
Injection, glucagon hydrochloride (fresenius kabi), not therapeutically equivalent to j1610, per 1 mg |
63 |
48 |
$4K |
| J3370 |
Injection, vancomycin hcl, 500 mg |
3,306 |
1,756 |
$4K |
| 87116 |
|
1,295 |
827 |
$4K |
| 82610 |
|
366 |
335 |
$4K |
| 73223 |
|
13 |
13 |
$3K |
| 82523 |
|
343 |
313 |
$3K |
| 76821 |
|
45 |
12 |
$3K |
| 85613 |
|
830 |
539 |
$3K |
| 84145 |
|
980 |
777 |
$3K |
| 0346T |
|
33 |
31 |
$3K |
| 87075 |
|
1,073 |
738 |
$3K |
| 80169 |
|
144 |
91 |
$3K |
| G0390 |
Trauma response team associated with hospital critical care service |
598 |
488 |
$3K |
| 87102 |
|
1,353 |
918 |
$3K |
| 72192 |
|
19 |
13 |
$3K |
| 85670 |
|
688 |
594 |
$3K |
| 82024 |
|
128 |
98 |
$3K |
| 84155 |
|
590 |
525 |
$3K |
| 51702 |
|
295 |
249 |
$3K |
| 88313 |
|
1,303 |
533 |
$3K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
4,220 |
2,588 |
$3K |
| 00142 |
|
2,789 |
2,054 |
$3K |
| 82085 |
|
225 |
192 |
$3K |
| J8501 |
Aprepitant, oral, 5 mg |
213 |
154 |
$3K |
| 80177 |
|
410 |
347 |
$3K |
| 82010 |
|
1,093 |
782 |
$3K |
| J2310 |
Injection, naloxone hydrochloride, per 1 mg |
270 |
165 |
$3K |
| M0239 |
Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring |
37 |
33 |
$3K |
| 80158 |
|
211 |
165 |
$3K |
| 82652 |
|
279 |
241 |
$3K |
| 88365 |
|
37 |
14 |
$3K |
| 87109 |
|
138 |
135 |
$3K |
| 86905 |
|
140 |
28 |
$2K |
| 86335 |
|
43 |
39 |
$2K |
| 84133 |
|
860 |
634 |
$2K |
| 84478 |
|
439 |
316 |
$2K |
| 76881 |
|
16 |
14 |
$2K |
| 76825 |
|
12 |
12 |
$2K |
| J2704 |
Injection, propofol, 10 mg |
33,104 |
19,568 |
$2K |
| 95992 |
|
24 |
16 |
$2K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
14,553 |
9,969 |
$2K |
| 92610 |
|
79 |
58 |
$2K |
| 97014 |
|
26 |
12 |
$2K |
| 95819 |
|
15 |
12 |
$2K |
| 80348 |
|
873 |
576 |
$2K |
| 87653 |
|
185 |
181 |
$2K |
| 00811 |
|
956 |
799 |
$2K |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
4,003 |
2,894 |
$2K |
| 86618 |
|
217 |
197 |
$2K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
4,299 |
2,747 |
$2K |
| 81256 |
|
15 |
13 |
$2K |
| 83935 |
|
645 |
434 |
$2K |
| 81382 |
|
93 |
74 |
$2K |
| 80202 |
|
135 |
80 |
$2K |
| 72220 |
|
35 |
30 |
$2K |
| 92060 |
|
17 |
16 |
$2K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
13,070 |
9,963 |
$2K |
| 85384 |
|
634 |
464 |
$2K |
| J1953 |
Injection, levetiracetam, 10 mg |
436 |
277 |
$2K |
| 64488 |
|
13 |
12 |
$2K |
| H2020 |
Therapeutic behavioral services, per diem |
47 |
15 |
$2K |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
3,625 |
2,513 |
$2K |
| 83090 |
|
341 |
312 |
$2K |
| 83930 |
|
809 |
635 |
$2K |
| 72083 |
|
26 |
17 |
$2K |
| 00840 |
|
675 |
465 |
$2K |
| J1644 |
Injection, heparin sodium, per 1000 units |
4,916 |
2,239 |
$2K |
| 86308 |
|
278 |
217 |
$2K |
| 86828 |
|
43 |
40 |
$2K |
| J3411 |
Injection, thiamine hcl, 100 mg |
824 |
214 |
$2K |
| M0245 |
Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring |
12 |
12 |
$2K |
| 86337 |
|
76 |
68 |
$2K |
| J0692 |
Injection, cefepime hydrochloride, 500 mg |
1,121 |
582 |
$2K |
| 0753T |
|
1,725 |
1,657 |
$2K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
71 |
68 |
$2K |
| 84432 |
|
70 |
64 |
$2K |
| 76942 |
|
1,198 |
895 |
$2K |
| 81596 |
|
26 |
26 |
$2K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
22,085 |
17,812 |
$2K |
| J0295 |
Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm |
1,917 |
740 |
$2K |
| 84295 |
|
2,015 |
1,343 |
$2K |
| 76827 |
|
13 |
12 |
$2K |
| 88304 |
|
1,006 |
739 |
$2K |
| 31629 |
|
17 |
12 |
$1K |
| 00400 |
|
366 |
292 |
$1K |
| 80179 |
|
962 |
804 |
$1K |
| 80195 |
|
152 |
109 |
$1K |
| 82239 |
|
92 |
77 |
$1K |
| J0689 |
Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg |
6,753 |
4,673 |
$1K |
| 00170 |
Anesthesia for intraoral procedures, including biopsy |
279 |
240 |
$1K |
| C2625 |
Stent, non-coronary, temporary, with delivery system |
648 |
529 |
$1K |
| 00537 |
|
18 |
12 |
$1K |
| 31628 |
|
20 |
13 |
$1K |
| G0237 |
Therapeutic procedures to increase strength or endurance of respiratory muscles, face to face, one on one, each 15 minutes (includes monitoring) |
29 |
28 |
$1K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
21,529 |
17,554 |
$1K |
| 01922 |
|
13 |
12 |
$1K |
| 99152 |
|
403 |
367 |
$1K |
| 80299 |
|
136 |
126 |
$1K |
| 29826 |
|
17 |
14 |
$1K |
| 00790 |
|
349 |
287 |
$1K |
| 85732 |
|
334 |
266 |
$1K |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
2,983 |
1,765 |
$1K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
2,715 |
2,069 |
$1K |
| 87385 |
|
109 |
78 |
$1K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
26,326 |
17,614 |
$1K |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
4,963 |
3,503 |
$1K |
| 93356 |
|
129 |
126 |
$1K |
| J1250 |
Injection, dobutamine hydrochloride, per 250 mg |
316 |
251 |
$1K |
| V2632 |
Posterior chamber intraocular lens |
174 |
144 |
$1K |
| 82378 |
|
120 |
106 |
$1K |
| 90656 |
|
101 |
99 |
$1K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
23,884 |
17,598 |
$1K |
| 80321 |
|
56 |
53 |
$1K |
| 80175 |
|
118 |
105 |
$1K |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
1,608 |
940 |
$998.46 |
| 01810 |
|
1,208 |
936 |
$994.51 |
| C1781 |
Mesh (implantable) |
267 |
210 |
$972.97 |
| 77002 |
|
145 |
120 |
$958.38 |
| 82542 |
|
70 |
55 |
$947.09 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
1,081 |
759 |
$918.51 |
| C9113 |
Injection, pantoprazole sodium, per vial |
324 |
159 |
$902.12 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
2,894 |
2,580 |
$895.84 |
| 70355 |
|
53 |
40 |
$866.11 |
| J0736 |
Injection, clindamycin phosphate, 300 mg |
471 |
309 |
$861.38 |
| 00300 |
|
496 |
403 |
$856.69 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
5,029 |
4,080 |
$847.57 |
| C1769 |
Guide wire |
2,936 |
2,281 |
$823.08 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
3,257 |
2,366 |
$818.76 |
| 00520 |
|
332 |
252 |
$778.36 |
| 00145 |
|
464 |
364 |
$754.77 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
6,000 |
4,260 |
$754.74 |
| 84445 |
|
32 |
32 |
$708.98 |
| 90678 |
|
101 |
83 |
$703.70 |
| 20561 |
|
20 |
12 |
$678.42 |
| 01400 |
|
553 |
404 |
$670.54 |
| 99153 |
Mod sedat endo service >5yrs |
301 |
274 |
$656.22 |
| 84080 |
|
59 |
55 |
$637.08 |
| 89060 |
|
106 |
99 |
$632.37 |
| 84255 |
|
55 |
53 |
$613.00 |
| 92609 |
|
14 |
13 |
$590.87 |
| 87535 |
|
13 |
13 |
$563.40 |
| 00120 |
|
54 |
50 |
$549.54 |
| 82810 |
|
833 |
353 |
$548.83 |
| 70250 |
|
51 |
36 |
$546.55 |
| 83835 |
|
30 |
30 |
$541.86 |
| J1790 |
Injection, droperidol, up to 5 mg |
2,044 |
1,536 |
$514.74 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
128 |
87 |
$495.59 |
| J2060 |
Injection, lorazepam, 2 mg |
2,118 |
1,431 |
$495.41 |
| 64636 |
|
90 |
59 |
$490.08 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
2,314 |
1,832 |
$472.50 |
| 93352 |
|
44 |
30 |
$469.94 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
1,008 |
815 |
$458.61 |
| 83695 |
|
50 |
49 |
$446.66 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
2,117 |
1,443 |
$442.47 |
| Q0247 |
Injection, sotrovimab, 500 mg |
87 |
85 |
$436.40 |
| 85549 |
|
66 |
58 |
$435.33 |
| 00732 |
|
510 |
349 |
$433.80 |
| 82805 |
|
455 |
423 |
$430.72 |
| 00320 |
|
154 |
65 |
$414.08 |
| J3480 |
Injection, potassium chloride, per 2 meq |
1,135 |
726 |
$408.97 |
| C1725 |
Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) |
278 |
204 |
$408.00 |
| 77012 |
|
89 |
71 |
$400.40 |
| 86363 |
|
49 |
40 |
$399.71 |
| 90662 |
|
35 |
28 |
$390.05 |
| 00812 |
|
131 |
110 |
$384.00 |
| 86777 |
|
41 |
30 |
$383.46 |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
755 |
621 |
$378.40 |
| 73565 |
|
12 |
12 |
$376.23 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
2,974 |
2,217 |
$375.28 |
| 85240 |
|
19 |
12 |
$360.23 |
| J1630 |
Injection, haloperidol, up to 5 mg |
3,136 |
2,345 |
$336.00 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
414 |
259 |
$335.66 |
| J1940 |
Injection, furosemide, up to 20 mg |
1,351 |
715 |
$333.23 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
3,462 |
2,243 |
$332.43 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
1,526 |
941 |
$314.93 |
| 80159 |
|
16 |
12 |
$307.07 |
| 86053 |
|
41 |
37 |
$301.40 |
| 82375 |
|
495 |
453 |
$298.56 |
| J1580 |
Injection, garamycin, gentamicin, up to 80 mg |
303 |
232 |
$287.20 |
| 82945 |
|
462 |
377 |
$286.50 |
| 01830 |
|
404 |
288 |
$274.77 |
| J2598 |
Injection, vasopressin, 1 unit |
422 |
351 |
$262.81 |
| 82657 |
|
16 |
16 |
$259.41 |
| 80156 |
|
13 |
13 |
$242.63 |
| 88108 |
|
44 |
31 |
$241.25 |
| 82787 |
|
27 |
14 |
$233.84 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
15 |
12 |
$229.48 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
5,136 |
2,068 |
$226.72 |
| 76510 |
|
14 |
12 |
$226.70 |
| 82365 |
|
93 |
77 |
$224.77 |
| 84540 |
|
51 |
37 |
$191.85 |
| 36416 |
|
3,393 |
3,184 |
$188.41 |
| 36591 |
|
20 |
15 |
$187.34 |
| G8982 |
Changing & maintaining body position functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
176 |
160 |
$186.33 |
| G0475 |
Hiv antigen/antibody, combination assay, screening |
537 |
517 |
$182.84 |
| 46600 |
|
139 |
132 |
$177.25 |
| 84157 |
|
458 |
372 |
$176.06 |
| 84252 |
|
14 |
13 |
$170.71 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
337 |
299 |
$160.81 |
| J0456 |
Injection, azithromycin, 500 mg |
437 |
289 |
$159.89 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
583 |
393 |
$152.75 |
| C1729 |
Catheter, drainage |
403 |
250 |
$151.44 |
| 86692 |
|
18 |
15 |
$151.17 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
1,545 |
1,128 |
$146.35 |
| J2785 |
Injection, regadenoson, 0.1 mg |
140 |
134 |
$144.36 |
| 86645 |
|
17 |
15 |
$143.23 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
299 |
274 |
$139.37 |
| G8981 |
Changing & maintaining body position functional limitation, current status, at therapy episode outset and at reporting intervals |
142 |
131 |
$137.96 |
| 83518 |
|
17 |
16 |
$132.09 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
228 |
131 |
$128.84 |
| 85300 |
|
30 |
28 |
$120.60 |
| 83050 |
|
480 |
436 |
$114.48 |
| 95907 |
|
429 |
409 |
$108.44 |
| J0461 |
Injection, atropine sulfate, 0.01 mg |
88 |
69 |
$107.07 |
| 0752T |
|
165 |
157 |
$103.90 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
447 |
387 |
$103.55 |
| J1805 |
Injection, esmolol hydrochloride, 10 mg |
571 |
483 |
$102.71 |
| 77001 |
|
79 |
56 |
$97.02 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
972 |
624 |
$95.52 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
1,138 |
990 |
$94.99 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
2,021 |
1,589 |
$94.84 |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
4,956 |
4,241 |
$91.01 |
| J3489 |
Injection, zoledronic acid, 1 mg |
19 |
19 |
$80.16 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
441 |
346 |
$75.99 |
| 88300 |
|
15 |
12 |
$74.50 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
1,256 |
915 |
$73.50 |
| J0737 |
Injection, clindamycin phosphate (baxter), not therapeutically equivalent to j0736, 300 mg |
112 |
97 |
$72.67 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
372 |
250 |
$72.23 |
| 97164 |
|
15 |
13 |
$69.39 |
| J1836 |
Injection, metronidazole, 10 mg |
317 |
191 |
$67.10 |
| J0744 |
Injection, ciprofloxacin for intravenous infusion, 200 mg |
425 |
301 |
$66.07 |
| 84436 |
|
13 |
13 |
$61.72 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
509 |
452 |
$59.30 |
| 88312 |
|
60 |
26 |
$53.66 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
1,292 |
1,121 |
$52.21 |
| J0688 |
Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg |
463 |
402 |
$46.91 |
| J1920 |
Injection, labetalol hydrochloride, 5 mg |
939 |
709 |
$46.58 |
| 88311 |
|
15 |
13 |
$39.03 |
| A9573 |
Injection, gadopiclenol, 1 ml |
2,910 |
2,747 |
$38.26 |
| J3360 |
Injection, diazepam, up to 5 mg |
35 |
26 |
$36.93 |
| Q9957 |
Injection, perflutren lipid microspheres, per ml |
875 |
718 |
$36.00 |
| Q0164 |
Prochlorperazine maleate, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
719 |
487 |
$32.47 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
1,136 |
856 |
$31.73 |
| 0754T |
|
195 |
181 |
$28.84 |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
102 |
82 |
$23.20 |
| J3260 |
Injection, tobramycin sulfate, up to 80 mg |
20 |
15 |
$23.14 |
| 87210 |
|
12 |
12 |
$20.87 |
| A9585 |
Injection, gadobutrol, 0.1 ml |
521 |
478 |
$18.24 |
| J7507 |
Tacrolimus, immediate release, oral, 1 mg |
196 |
63 |
$18.21 |
| J2720 |
Injection, protamine sulfate, per 10 mg |
19 |
13 |
$17.96 |
| G8980 |
Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting |
16 |
15 |
$16.89 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
224 |
197 |
$13.49 |
| J0173 |
Injection, epinephrine (belcher), not therapeutically equivalent to j0171, 0.1 mg |
372 |
333 |
$13.20 |
| J7517 |
Mycophenolate mofetil, oral, 250 mg |
66 |
27 |
$8.66 |
| Q0169 |
Promethazine hydrochloride, 12.5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
423 |
233 |
$4.86 |
| 74328 |
|
245 |
180 |
$4.36 |
| 87305 |
|
26 |
12 |
$4.06 |
| J2004 |
Injection, lidocaine hcl with epinephrine, 1 mg |
21 |
21 |
$3.75 |
| Q0243 |
Injection, casirivimab and imdevimab, 2400 mg |
119 |
63 |
$1.04 |
| J0612 |
Injection, calcium gluconate, not otherwise specified, 10 mg |
50 |
38 |
$0.78 |
| Q0244 |
Injection, casirivimab and imdevimab, 1200 mg |
75 |
72 |
$0.67 |
| Q0239 |
Injection, bamlanivimab-xxxx, 700 mg |
14 |
14 |
$0.14 |
| Q0245 |
Injection, bamlanivimab and etesevimab, 2100 mg |
12 |
12 |
$0.06 |
| 00910 |
|
191 |
158 |
$0.00 |
| 00918 |
|
153 |
106 |
$0.00 |
| M0222 |
Intravenous injection, bebtelovimab, includes injection and post administration monitoring |
69 |
66 |
$0.00 |
| 00402 |
|
140 |
115 |
$0.00 |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
794 |
598 |
$0.00 |
| 00140 |
|
168 |
127 |
$0.00 |
| C1760 |
Closure device, vascular (implantable/insertable) |
250 |
185 |
$0.00 |
| 01630 |
|
274 |
183 |
$0.00 |
| 01202 |
|
12 |
12 |
$0.00 |
| A9541 |
Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries |
500 |
445 |
$0.00 |
| 01402 |
|
34 |
27 |
$0.00 |
| C1874 |
Stent, coated/covered, with delivery system |
31 |
24 |
$0.00 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
108 |
107 |
$0.00 |
| C1762 |
Connective tissue, human (includes fascia lata) |
60 |
45 |
$0.00 |
| C1751 |
Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) |
56 |
43 |
$0.00 |
| 76376 |
|
29 |
27 |
$0.00 |
| 88302 |
|
90 |
51 |
$0.00 |
| A9537 |
Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries |
13 |
12 |
$0.00 |
| C1730 |
Catheter, electrophysiology, diagnostic, other than 3d mapping (19 or fewer electrodes) |
269 |
219 |
$0.00 |
| 00902 |
|
60 |
51 |
$0.00 |
| C1726 |
Catheter, balloon dilatation, non-vascular |
946 |
733 |
$0.00 |
| 76377 |
|
898 |
784 |
$0.00 |
| 01214 |
|
82 |
62 |
$0.00 |
| 00813 |
|
450 |
379 |
$0.00 |
| 01480 |
|
224 |
173 |
$0.00 |
| C1889 |
Implantable/insertable device, not otherwise classified |
16 |
15 |
$0.00 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
236 |
224 |
$0.00 |
| A9503 |
Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries |
89 |
88 |
$0.00 |
| J1720 |
Injection, hydrocortisone sodium succinate, up to 100 mg |
19 |
13 |
$0.00 |
| 00160 |
|
56 |
43 |
$0.00 |
| 80349 |
|
15 |
13 |
$0.00 |
| 36226 |
|
36 |
27 |
$0.00 |
| C1778 |
Lead, neurostimulator (implantable) |
14 |
12 |
$0.00 |
| 73501 |
|
29 |
25 |
$0.00 |
| 00952 |
|
14 |
12 |
$0.00 |